Navigation Links
Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis

designed to evaluate the safety and efficacy of ACTEMRA plus methotrexate (4 mg/kg or 8 mg/kg) compared to placebo plus methotrexate in RA patients who had an inadequate response to anti-TNFs alone. Patients received either ACTEMRA intravenously (4 mg/kg or 8 mg/kg) every four weeks plus methotrexate weekly or placebo infusions every four weeks plus methotrexate weekly.

Data from the study were analyzed to determine patients' response to treatment by using three standard assessments: ACR score (1), developed by the of Rheumatology (ACR), DAS28 (2), a measurement of RA disease activity, and EULAR response criteria (3), a measurement of treatment response. The study included 498 patients at 128 trial sites in 13 countries, including the United States.

The RADIATE trial is one of five Phase III clinical studies designed to investigate ACTEMRA as a potential new treatment for RA. Roche and Chugai have initiated the collaborative clinical development program that has enrolled a total of more than 4,000 patients in 41 countries including the United States and several European countries.

About ACTEMRA (tocilizumab)

ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody and represents a novel mechanism of action to treat RA. Studies suggest that reducing the activity of IL-6, one of several key cytokines involved in the inflammatory process, may reduce inflammation of the joints. The global ACTEMRA Phase III clinical development program is designed to evaluate this clinical finding. The compound is not currently approved in the United States.

The most common adverse events reported in ACTEMRA global clinical studies are upper respiratory tract infections, headache, nasopharyngitis and hypertension. As with other biological disease modifying anti-rheumatic drugs (DMARDs), serious infections have been reported in some patients treated with ACTEMRA.

About Rheumatoid Arthritis

Rheumatoid arth
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
2. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
3. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
4. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
5. One-Third of Patients Discontinue Common Breast Cancer Therapy
6. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:10/22/2014)...  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that James ... has been elected to the Company,s Board of Directors, ... Anderson , Executive Chairman of CryoLife, stated, "Since joining the ... excellent leader who is well positioned to maximize CryoLife,s ...
(Date:10/22/2014)... LOUIS , Oct. 21, 2014  Early ... often subtle or unnoticed, but new technology, coupled ... outcomes and leading to earlier detection of eye ... affects 29 million Americans. If left untreated, these ... even blindness. Recently, optometric researchers ...
(Date:10/22/2014)... InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based ... spinal cord injury (SCI) treatment with their novel Neuro-Spinal ... tissue regrowth in the spinal cord area when cells ... approved polymer, the scaffold ultimately breaks down to water ... body. NVIV has recently attracted significant investor attention with ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... MedPro Imaging, a premium provider ... the expansion of its operations with the opening ... in Longmont, Colo.  The 5,000-square foot facility features ... U.S. market, offering high quality computer-based transducer repair ...
... Botanic Pharmaceutical Inc. (NYSE AMEX: CBP ) ... distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ... successfully completed a feasibility study to analyze the benefits ... production operations. As a result of the study, the ...
Cached Medicine Technology:MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 2MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 3China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 2China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 3
(Date:10/25/2014)... York (PRWEB) October 25, 2014 ... lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston ... in U.S. District Court, Southern District of West ... Judgment on Punitive Damages in a group of ... a ruling issued on October 21st, U.S. District ...
(Date:10/25/2014)... supply to an arm or a leg before heart surgery ... to a new study. "During heart surgery we ... be able to operate on it. After some time without ... energy because it doesn,t get oxygen. When we shut off ... arm or a leg, the body prepares for an upcoming ...
(Date:10/25/2014)... (HealthDay News) -- Researchers who discovered antibiotics in ... cause for concern. The use of antibiotics ... human consumption contribute to the development of antibiotic-resistant ... information from the study. Each year in ... million people and kill about 23,000, according to ...
(Date:10/25/2014)... Randy Dotinga HealthDay Reporter ... tests are developed that spot increased risks for certain cancers, ... about getting screened. But a new study suggests that, ... People who found out their genes doubled their risk of ... risk to get screened. "It didn,t make any difference, ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... effective treatments for cancer patients, it is essential to ... the disease. A team of scientists from the ... system which aims to pinpoint potential "biomarkers" of early ... at the structures of specific sugar molecules which are ...
... Staffers from West Jefferson Medical Center and East Jefferson ... St. Luke,s Hospital, CEDAR RAPIDS, Iowa, July 9 ... hospitals that operated,during Hurricane Katrina will caravan to Iowa ... by the Iowa Flood of 2008., Nicknamed, "Big ...
... WASHINGTON, July 9 The following is a,statement ... "Today the American Medical Association celebrates that ... and voted to stop Medicare,physician payment cuts that ... a,bipartisan, veto-proof majority of 69 to 30. We ...
... The Pharmaceutical Care,Management Association (PCMA) released the ... which includes a provision that requires,physicians to use ... of an e-prescribing requirement in Medicare is a ... e-prescribing,is the most important issue in the Medicare ...
... 9 Exponent, Inc.,(Nasdaq: EXPO ), today announced ... ended June 27, 2008, immediately following the close of,the ... host a,corresponding conference call and live webcast at 4:30 ... and Chief Executive,Officer, and Richard Schlenker, Chief Financial Officer, ...
... A lawsuit charges,pharmaceutical giant Pfizer was motivated by ... potentially deadly side-effects associated with its popular,smoking cessation ... name,Chantix. The suit, brought by the widow of ... using Chantix as prescribed. The victim,s,tragic death occurred ...
Cached Medicine News:Health News:A short and sweet diagnosis for cancer? 2Health News:'Big Relief From the Big Easy' Headed to Cedar Rapids Hospital 2Health News:Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris 2
This is long known for its purity and mildness, Castile Soap is also an effective cleaning agent that is used in a variety of applications. It rinses clean while leaving the skin soft and healthy....
... This antimicrobial skin cleanser will not leave ... with frequent washings. With persistent Antimicrobial action, ... of microorganisms, including gram-negative and gram-positive bacteria, ... as a 15 second hand wash. The ...
... Protectant Prep Pads prepares the skin for ... When dry, it leaves a thin film ... clean surface and a barrier for natural ... of a dressing or tape. Skin Protectant ...
... Povidone Iodine Prep Pads ... surface pathogens including bacteria, ... yeast. Povidone Iodine is ... wounds or mucus membranes. ...
Medicine Products: